Clinical Trials Logo

Transgenderism clinical trials

View clinical trials related to Transgenderism.

Filter by:

NCT ID: NCT04969003 Completed - Depression Clinical Trials

Reducing Transphobia Among Adolescents Through a Brief Video Intervention

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

The purposes of this new study are to test among adolescent viewers the utility of brief video-based interventions to: 1. reduce transphobia; 2. reduce depression-related stigma and increase likelihood of treatment-seeking; and 3. examine the role of viewer's sex (male / female / non-binary), race (Black vs non-Black), and sexual orientation (straight vs LGBQ) as independent factors on the outcomes of interest.

NCT ID: NCT04838249 Recruiting - Eating Behavior Clinical Trials

Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System

HHS
Start date: May 5, 2021
Phase:
Study type: Observational

Current study aims to characterize five highly interconnected physiological systems in patients undergoing cross-sex hormone therapy - namely glucose and lipid metabolism, energy balance, eating behavior, functional brain networks involved in the regulation of eating behavior and the cardiovascular system - to gain novel insights into the effects of sex hormones on the human body. Gathered information will help to identify pathophysiological mechanisms for the development of overeating/obesity, insulin resistance, and cardiovascular disease. Secondarily, the relationships between the gut and oral microbiomes and metabolomes and circulating bacterial signatures will be investigated in relation to the other pervasive physiological systems. Current study is an observational study. The decision if the patient's request for cross-sex hormone therapy can complied with (i.e., if cross-sex hormone therapy is medically indicated) is made prior to the first contact with the study center and with the outpatients clinic for Endocrinology at the University Hospital in Leipzig. Decision ifor treatment is made according to national and international guidelines. Treatment of study participants with testosterone and estradiol/antiandrogens is not affected by the study. During the course of the study no invasive interventions are being performed.

NCT ID: NCT04708600 Completed - Gender Dysphoria Clinical Trials

Effectiveness of Speech Therapy in Trans Women.

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

One of the greatest hurdles in the transition of transgender persons is that voice, speech and communication are not congruent with the desired gender. Since hormone treatment does not affect the voice in male-to-female transgender persons (trans women), speech therapy is the treatment of choice to develop a more feminine communication. Speech therapy must focus on aspects of communication that play an important role in listener perceptions of the speakers gender. Results of a systematic review and meta-analysis showed that those aspects are primarily fundamental frequency of the voice and resonance. However, effectiveness studies of speech interventions in transwomen are extremely limited and show methodological limitations. The purpose of this project is to investigate the short-term and longterm impact of speech exercises for pitch and resonance on (a) acoustic voice characteristics, (b) listener perceptions of femininity using a visual analogue scale and binary gender identification (male versus female voice), and (c) self-perception and psychosocial functioning in trans women using a randomized sham-controlled trial and cross-over design.

NCT ID: NCT04596592 Recruiting - Insulin Sensitivity Clinical Trials

Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth

PUBERTY
Start date: February 15, 2021
Phase:
Study type: Observational

To evaluate the effect of estradiol with or without a prior gonadotropin releasing hormone analogue on insulin sensitivity and vascular function in transgender females compared to cisgender controls.

NCT ID: NCT04551144 Terminated - Transgenderism Clinical Trials

Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors

Start date: October 6, 2020
Phase:
Study type: Observational

The purpose of this research is to find out if hormone therapy in transgender subjects' changes hormone receptors in blood, muscle and fat; fat production; muscle production; and inflammation processes.

NCT ID: NCT04545450 Completed - Hypogonadism Clinical Trials

Effects of Testosterone Plus Dutasteride or Placebo on Muscle Strength, Body Composition and Metabolism in Transmen

DUTMUSCLE-20
Start date: November 4, 2008
Phase: Phase 3
Study type: Interventional

To compare the effects on body composition and muscle strengthof 54-weeks treatment with of testosterone undecanoate combined with placebo or with the 5a-reductase inhibitor dutasteride

NCT ID: NCT04515654 Completed - Stigma, Social Clinical Trials

Supporting Trans Identities and Occupational Justice Through Narrative Informed Theatre: Supporting Trans Identities and Occupational Justice Through Narrative Informed Theatre

Start date: January 15, 2019
Phase: N/A
Study type: Interventional

Importance: Societal stigma gravely impedes occupational justice for trans individuals, producing vast health disparities for this population. Objective: Test feasibility and impact of an intervention to reduce stigma and improve trans wellbeing Design: Convergent parallel mixed methods Setting: Community/Webinar Participants: 42 audience members and 6 trans interviewees Intervention: Virtual, narrative-informed play reading and moderated discussion about gender diversity and affirmative care Outcomes and Measures: The valid and reliable Acceptance and Action Questionnaire - Stigma (AAQ-S) assesses stigma beliefs; An open-ended qualitative question assesses trans interviewees' experiences

NCT ID: NCT04482920 Completed - Kidney Diseases Clinical Trials

Effect of Hormone Therapy on Renal Function

Start date: April 15, 2021
Phase:
Study type: Observational

The purpose of this study is to understand the effects of testosterone or estradiol on kidney function in transgender adolescents and young adults.

NCT ID: NCT04482374 Recruiting - Clinical trials for Endothelial Dysfunction

Puberty Suppression and Cardiometabolic Health

Start date: August 10, 2020
Phase:
Study type: Observational

This observational study will evaluate the effect of puberty suppression on insulin sensitivity, metabolic rate and vascular health among transgender female youth at baseline and 6 months after initiation of a gondoatropin releasing hormone agonist compared to matched cisgender male controls.

NCT ID: NCT04454970 Completed - Transgenderism Clinical Trials

Safe Access for Bladder Entry in Transgender Men Following Penile Reconstruction

SAFE
Start date: September 16, 2022
Phase: N/A
Study type: Interventional

Inserting a urinary catheter in transgender men following penile reconstruction is difficult and usually requires specialist input. Specialist input may not always be readily available and clinicians may resort to suprapubic catheterisation with the associated risk of injury to the bowel or blood vessels. There is a need for an evidence-based protocol to guide clinicians faced with having to catheterise one of these patients. The investigators will evaluate how successful a specialised catheter (Urethrotech UCD®) is compared with a standard Foley catheter for catheterisation of these patients. The Urethrotech UCD® is already used for difficult catheterisation in cisgender men. Transgender men undergoing insertion of an inflatable penile prosthesis under general anaesthesia will be recruited and randomly assigned to have either the Urethrotech UCD® or Foley catheter for the first attempt at urethral catheterisation (required for standard care). If unsuccessful, flexible cystoscopy will be performed and a Foley catheter will be inserted over a guidewire. The catheter is generally removed the next day prior to discharge from hospital. Patients will be followed-up in 30 days by phone.